- POSITIVE
Annual Revenue Biopol Chemicals Mar-2026 Annual Revenue is Rs 81 Cr which is growth of 65.6% YoY.
- POSITIVE
Annual Net Profit Biopol Chemicals Mar-2026 Annual Net Profit is Rs 9 Cr which is growth of 107.2% YoY.
Biopol Chemicals was incorporated on April 12, 2023. The company is engaged in trading, manufacturing, and distribution of specialty chemicals across silicones, emulsifiers, biochemicals, and polyelectrolytes. Its portfolio of 66 products serves diverse applications in textiles, home care, agriculture, and industrial chemicals
| Bidding Dates |
|---|
| 06 Feb 2026 - 10 Feb 2026 |
| Subscription |
|---|
| 21.22x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹244,800 | 2 | 2 | 1200 | 2.9 M | ₹102 - ₹108 | 65.81 % | ₹295.2 M - ₹312.6 M | RHP DOC |
Biopol Chemicals IPO SUBSCRIPTION STATUS
10 Feb '26Total21.22x
Retail Individual Investor19.76x
HNI (NII) Investors62.07x
Qualified Institutional Buyers9.98x
Biopol Chemicals IPO overall subscription rate was 21.22 times the total available shares
Biopol Chemicals IPO retail subscription rate was 19.76 times in the retail segment
Biopol Chemicals IPO non-institutional investor subscription rate was 62.07 times in the non-institutional investor category
Biopol Chemicals IPO Qualified Institutional Bidder subscription rate was 9.98 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
10 Feb 2026 (Day 3) | 19.76x | 62.07x | 9.98x |
09 Feb 2026 (Day 2) | 0.95x | 2.34x | 1.9x |
06 Feb 2026 (Day 1) | 0.18x | 0.39x | - |
Biopol Chemicals FINANCIALS
| Period | Revenue from Operations (Rs in crore) | Net Profit (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| 9MFY26 | 48.8 | 6.0 | -4.3 | -4.5 | 18.4% |
| FY25 | 49.1 | 4.3 | -2.3 | -2.4 | 13.3% |
| FY24 | 25.5 | 3.0 | -8.9 | -8.9 | 17.4% |
Biopol Chemicals IPO SUBSCRIPTION STATUS DETAILS
Biopol Chemicals had 2.9 M shares on offer
Biopol Chemicals IPO offer price was in the range ₹102 - ₹108
Biopol Chemicals IPO minimum Investment was ₹244800
Biopol Chemicals IPO issue size was ₹ 295.2 M - ₹ 312.6 M
Biopol Chemicals had a minimum lot size of 1200 Shares per application
Biopol Chemicals NUMBER OF SHARES ON OFFER
Total2.9 M
Fresh Issue2.9 M
Offer for Sale0
Post Issue Promoter Holding %65.81 %
Biopol Chemicals IPO IMPORTANT DATES
| Issue Open Date | 06 Feb 2026 |
| Issue close Date | 10 Feb 2026 |
| Allotment Date | 11 Feb 2026 |
| Refund Date | 12 Feb 2026 |
| Demat Account Credit Date | 12 Feb 2026 |
| Listing Date | 13 Feb 2026 |
| Listing on Exchange(s) | NSE |
| Biopol Chemicals Allotment Status | Exchange/ Registrar |
Biopol Chemicals IPO subscription opened on 06 Feb 2026, and closed on 10 Feb 2026
IPO allotment for Biopol Chemicals was finalized on Wednesday, 11 Feb 2026
IPO listing for Biopol Chemicals was on NSE on Friday, 13 Feb 2026
Biopol Chemicals IPO LISTING GAINS
| Issue Price (adjusted) | 108.0 |
| Listing Open Price | 111.0 |
| Listing Close Price | 105.5 |
| Listing Gain% | 2.8% |
| Current Gain% | -56.9% |
Biopol Chemicals Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biopol Chemicals Ltd. | 46.5 | 50.2 | 5.6 | 0.1 | 0.6 | 18 | 12.9 | 81.4 | 65.6 | 9 | 107.2 | 8.3 | 107.2 |
| Pidilite Industries Ltd. | 1461.6 | 148869.8 | 55.5 | 2.7 | 9.2 | 22.6 | 15.9 | 14867 | 11.1 | 2448.9 | 17.9 | 26.4 | 20.6 |
| SRF Ltd. | 2335.5 | 69230 | 30.3 | 0.7 | 3.8 | 13.1 | 7.6 | 15893.6 | 7.2 | 1835.2 | 46.7 | 77 | 41.1 |
| Gujarat Fluorochemicals Ltd. | 4248.2 | 46666.5 | 75.9 | -67.4 | 8.8 | 7.3 | 4.8 | 5126.3 | 5.6 | 577.4 | 5.7 | 56 | -1.1 |
| Himadri Speciality Chemical Ltd. | 509.2 | 25692.9 | 30.1 | 1 | 4.6 | 16 | 11.9 | 4832 | 3.6 | 751.3 | 35.2 | 16.9 | 30.3 |
| Aether Industries Ltd. | 1616.2 | 21451.5 | 86.1 | 3.1 | 16.6 | 8.9 | 6.8 | 1181.1 | 34.2 | 219.5 | 38.5 | 18.8 | 28 |
Annual
Balance Sheet
Ratios
Cash Flow
Biopol Chemicals annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 |
|---|---|---|---|---|---|---|
61.6% | 81.4 | 49.2 | 25.5 | 19.3 | ||
Operating Exp. Ann. | 56.1% | 67.7 | 42.6 | 21 | 17.8 | |
Operating Profit Ann. | 103.6% | 13.5 | 6.5 | 4.4 | 1.6 | |
OPM Ann. % | 27.1% | 16.53% | 13.29% | 17.38% | 8.06% | |
55% | 69.3 | 43.4 | 21.5 | 18.6 | ||
EBITDA Ann. | 104.6% | 13.7 | 6.6 | 4.4 | 1.6 | |
EBITDA Ann. margin % | 27.6% | 16.81% | 13.34% | 17.38% | 8.09% | |
Interest Ann. | 23.3% | 1.5 | 0.7 | 0.4 | 0.8 | |
Depr. | 0% | 0.1 | 0.1 | 0.1 | 0.1 | |
PBT Ann. | 158.6% | 12.1 | 5.8 | 4 | 0.7 | |
Tax Ann. | 149.3% | 3.1 | 1.5 | 1 | 0.2 | |
162.1% | 9 | 4.3 | 3 | 0.5 | ||
Net Profit Ann. | 162.1% | 9 | 4.3 | 3 | 0.5 | |
NPM Ann. % | 59.6% | 11.05% | 8.81% | 11.63% | 2.72% | |
EPS Adj. latest Ann. | 155.1% | 8.3 | 4 | 2.7 | 0.5 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
65.4%
2Y CAGR
78.7%
3Y CAGR
61.6%
Net Profit Ann.
1Y CHG
109.3%
2Y CAGR
73.2%
3Y CAGR
162.1%
Operating Exp. Ann.
1Y CHG
58.9%
2Y CAGR
79.5%
3Y CAGR
56.1%
Biopol Chemicals INFORMATION ON IPO ISSUE
About Biopol Chemicals
Biopol Chemicals was incorporated on April 12, 2023. The company is engaged in trading, manufacturing, and distribution of specialty chemicals across silicones, emulsifiers, biochemicals, and polyelectrolytes. Its portfolio of 66 products serves diverse applications in textiles, home care, agriculture, and industrial chemicals
Object of the Issue
- Acquisition of industrial land
- Repayment or prepayment, in full or in part, of borrowings availed by the company from banks, financial institutions and non-banking financial companies
- General corporate purposes
Biopol Chemicals - PROMOTERS
| Name |
|---|
| Santanu Sarkar |
| Vedant Sarkar |
Biopol Chemicals - MANAGEMENT & LEADERSHIP
| Name | Designation |
|---|---|
| Santanu Sarkar | Chairman & Managing Director |
| Vedant Sarkar | Whole Time Director |
| Preety Priya Ghosh | Non-Executive Independent Director |
| Gaurav Mittal | Non-Executive Independent Director |
| Kaushikkumar Vasantbhai Darji | Non-Executive Independent Director |
Biopol Chemicals Book Running Lead Manager
Smart Horizon Capital Advisors Private Limited
director@shcapl.com
Biopol Chemicals Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Biopol Chemicals Strengths
Order book
The company has a confirmed order book of approximately Rs 13.30 crore, excluding applicable taxes, based on customer purchase orders. Order execution typically takes 1 to 3 months, depending on product type, order size, and customer requirements
Strength
Quality certification & assurance
The company’s manufacturing facility is accredited with ISO 9001, ISO 14001, and ISO 45001 certifications, reflecting strong quality, environmental, and safety standards in specialty chemical manufacturing. It also holds ZDHC Level 3 certification for 42 products, demonstrating compliance with the highest industry and regulatory benchmarks
Strength
Export operations in Bangladesh
The company has a consistent export presence in Bangladesh, with exports contributing a meaningful share of total revenues across recent periods. Regular exports and active participation in industry exhibitions in Bangladesh strengthen market acceptance, visibility, and international competitiveness
Strength
Biopol Chemicals Risks
Depend on textile industry
The company’s specialty chemicals are primarily used in textile applications, making its business highly dependent on the textile industry. Any slowdown in this sector could significantly impact revenues, operations, and overall financial performance
Risk
Project expansion & execution risks
The company’s expansion plans, including acquiring industrial land in Gujarat, involve operational, regulatory, and execution risks that may affect timelines and outcomes. Any delays or inability to complete the project could adversely impact manufacturing capacity, operations, and financial performance
Risk
Operational risks
The company generates revenue from manufacturing, trading, and technical consultancy, making its performance dependent on the stability of all three segments. Any decline in demand, operational inefficiencies, or disruptions in these activities could adversely affect revenues, cash flows, and overall financial performance
Risk
IPO FAQs
The promoters of the company are Santanu Sarkar and Vedant Sarkar.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 102.0 - 108.0.
The IPO application opens on Feb 06, 2026 and closes on Feb 10, 2026.
The minimum lot size for the IPO is 2400. The maximum lot size for the IPO is 2400.
For all category investors, the minimum application amount for this IPO is Rs. 244,800.0, the maximum value for this IPO is Rs 259,200.0.
This IPO will be allotted on Feb 11, 2026.
The refund will be credited to your account on Feb 12, 2026.
The allotted shares will be credited to your demat on Feb 12, 2026.
Biopol Chemicals Ltd.’s shares listed on the stock exchanges on Feb 13, 2026.